1. Stolc S., Bauer V., Benes L., Tichy Z. (1983): Medicine with antiarrhythmic and antihypoxic activity and its method of preparation. Patents: CS 229067, SWED. 8204693-9, BELG. 894148, SWISS 651754, BRD P-3231088, SPAIN 553017, JAP. 1514040.
2. Horáková Ĺ., Stolc S. (1998): Review: antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen. Pharmacol., 30: 627–638.
3. Stefek M., Benes Ĺ., Jergelová M., Scasnár V., Turi-Nagy L., Kocis P. (1987): Biotransformation of stobadine, a γ-carboline antiarrhythmic and cardioprotective agent, in rat liver microsomes. Xenobiotica, 17: 1067–1073.
4. Scasnár V., Stefek M. (1987): Solvent extraction and radiometric determination of [3H]-stobadine in biological material. J. Radioanal. Nucl. Chem., 111: 117–122.
5. Kállay Z., Bittererová J., Brejcha A., Fáberová V., Bezek S., Trnovec T. (1990): Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agent cis(−)-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido-[4,3b-b] indole dihydrochloride in rats. Arzneimittelforschung, 40: 974–979.